Cloaking System Using Optoelectronically Controlled Camouflage
A Cloaking System designed to operate in the visible light spectrum, utilizes optoelectronics and/or photonic components to conceal an object within it.
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7994360 | Benzofuran compounds The present invention relates to benzofuran derivatives for use in antiviral compositions. More specifically, the present invention relates to compositions and methods for the treatment of hepatitis C virus by administering the benzofuran derivatives in a therapeuti... | 08/09/2011 |
| 7687659 | Process for the separation of probucol derivatives Provided are methods for the separation of mono-substituted probucol derivatives from a mixture of both mono- and di-substituted probucol derivatives. In particular, methods are provided for the separation of mono-carboxy substituted probucol derivatives from a mixt... | 03/30/2010 |
| 7465820 | Abiotic heparin antagonists The present invention relates to heparin-binding calixarene compounds of general Formula (I) in which R, R1, L and n have the meanings indicated in the description and their use in the biomedical field. ... | 12/16/2008 |
| 7304018 | Amidoacetonitrile compounds and their use as pesticides The invention relates to compounds of the general formula: (I) and optionally the enantiomers thereof. The active ingredients have advantages pesticidal properties. They are especially suitable for controlling parasites on warm-blooded animals. ... | 12/04/2007 |
| 7201876 | Ion-detecting sensors comprising plasticizer-free copolymers Ion-detecting sensors for detecting a target ion in a sample are provided. The sensor comprises a plasticizer-free copolymer comprised of polymerized units of methacrylate monomers having pendent alkyl groups of different length and a functionalized ionophore of sai... | 04/10/2007 |
| 7148002 | Nucleic acids and polypeptides related to a guanine exchange factor of Rho GTPase The present invention relates to all aspects of a guanine exchange factor (GEF), for example, a Rho-GEF, such as p115 Rho-GEF. A GEF modulates cell signaling pathways, both in in vitro and in vivo, by modulating the activity of a GTPase. By way of illustration, a p1... | 12/12/2006 |
| 7084316 | Process for purifying pentafluoroethane, process for producing the same, and use thereof A process comprising bringing crude pentafluoroethane containing at least one compound selected from the group consisting of hydrofluorocarbons containing one carbon atom, hydrochlorofluorocarbons containing one carbon atom and hydrochlorocarbons containing one carb... | 08/01/2006 |
| 7084151 | 5-(1',1'-cycloalkyl/alkenyl)methylidene 1,2-dihydro--chromeno[3,4-ƒ]quinolines as selective progesterone receptor modulator compounds The present invention is directed to compounds, pharmaceutical compositions, and methods for modulating processes mediated by Progesterone Receptor. Also provided are methods of making such compounds and pharmaceutical compositions. ... | 08/01/2006 |
| 7081457 | Cyclothiocarbamate derivatives as progesterone receptor modulators Methods of using compounds which are progesterone receptor agonists for contraception and the treatment of progesterone-related maladies alone or in combination with an estrogen receptor agonist or progesterone receptor antagonist are provided. These compounds have ... | 07/25/2006 |
| 7071205 | 5-cycloalkenyl 5H-chromeno[3,4-f]quinoline derivatives as selective progesterone receptor modulator compounds The present invention is directed to compounds, pharmaceutical compositions, and methods for modulating processes mediated by Progesterone Receptor. Also provided are methods of making such compounds and pharmaceutical compositions. ... | 07/04/2006 |
| 7022873 | Antibiotics Cyan-416 A, Cyan-416 B, Cyan-416 C, Cyan-416 D and Cyan-416 E, and ester derivatives of Cyan-416 B The invention relates to new antibiotics designated Cyan-416A, Cyan 416B, Cyan-416C, Cyan-416D and Cyan-416E to their production by fermentation of Acremonium sp. NRRL 30631 to methods for recovery and concentration from the crude solutions, and to a process ... | 04/04/2006 |
| 6964973 | Bicyclic androgen and progesterone receptor modulator compounds and methods The present invention is directed to compounds, pharmaceutical compositions, and methods for modulating processes mediated by AR and PR. More particularly, the invention relates to nonsteroidal compounds and compositions that are high affinity, high specificity agon... | 11/15/2005 |
| 6958411 | Nordihydroguaiartic derivatives for use in treatment of tumors Nordihydroguaiaretic acid derivatives and methods of use thereof for the treatment of tumors. ... | 10/25/2005 |
| 6858650 | Stable salts of novel derivatives of 3,3-diphenylpropylamines The present invention concerns highly pure, crystalline, stable compounds of novel derivatives of 3,3-diphenylpropylamines in the form of their salts, a method for the manufacture and highly pure, stable intermediate products. The method is in particular char... | 02/22/2005 |
| 6709824 | Parallel combinatorial approach to the discovery and optimization of catalysts and uses thereof The present invention provides methods and compositions, i.e. synthetic libraries of candidate compounds, useful in the discovery and optimization of compounds which catalyze at least one chemical transformation. In certain instances, the subject compounds catalyze ... | 03/23/2004 |
| 6706839 | Chemical partitioning agents and methods of using same The present invention is directed to partitioning agents and methods of using same to effectuate separation of a reactant, intermediate product, and/or final product from a reaction mixture while minimizing the need for traditional separation or isolation techniques... | 03/16/2004 |
| 6624193 | Preventive and therapeutic agents for eye diseases The present invention provides a prophylactic and therapeutic medicament for ophthalmic diseases, especially ophthalmic inflammatory diseases and corneal ulcer, comprising as an active ingredient a compound represented by the formula (I): ##STR1## or... | 09/23/2003 |
| 6620946 | Low shrinkage thermosetting resin compositions and methods of use thereof In accordance with the present invention, there are provided thermosetting resin compositions with a reduced propensity to shrink in volume upon cure and methods of use therefor. The compositions of the present invention include compounds having aromatic,... | 09/16/2003 |
| 6489365 | Amidine derivatives, the preparation and use thereof as medicaments with Itb4 antagonistic effect Compounds of the formula ##STR1## which is explained more fully in the specification, may be prepared by conventional methods and used therapeutically in conventional galenic preparations.... | 12/03/2002 |
| 6380181 | Synthetic catechol derivatives, method for production and use thereof Catechol derivatives of general formula (I) ##STR1## in which R1 denotes O-acyl and R2 represents amino acid residues in the 3- and/or 4-position function as siderophores and/or as biological chelating agents for iron in gram-negativ... | 04/30/2002 |
| 6365671 | Compositions containing cyanate ester and aromatic compounds having improved heat release properties The present invention relates to compositions of matter containing aromatic cyanate ester containing at least two rings linked by a group containing an unsaturated group and selected aromatic hydroxyl compounds that exhibited improved heat release and cur... | 04/02/2002 |
| 6284918 | Selective inhibitors of prostaglandin endoperoxide synthase-2 The present invention provides a compound of the formula ##STR1## wherein when X is S; R is selected from the group consisting of CH3, CH2 CH3, CH2 Ph, (CH2)2 Ph, (CH2)2 ... | 09/04/2001 |
| 6242638 | Cyanate esters having flame resistant properties The present invention relates to novel aromatic cyanate ester compounds containing at least two rings linked by a group containing an unsaturated group. The present invention further relates to compositions and prepolymers of said novel aromatic cyanate e... | 06/05/2001 |
| 6225499 | Process for preparing aminoarylacetylenes This invention provides a process for preparing aminoarylacetylenes comprising reacting a N-arylmethylidene aminoarylhalide with a terminal acetylene in the presence of a base and a catalyst system comprising a palladium catalyst and a cuprous salt to pro... | 05/01/2001 |
| 6215029 | Process for the preparation of halogenated hydroxydiphenyl compounds A process for the preparation of halohydroxydiphenyl compounds useful for protecting organic materials and articles from microorganisms, of the formula ##STR1## by acylation of a halogenated benzene compound (first stage), etherification of the acyla... | 04/10/2001 |
| 6147250 | Compounds and methods for the inhibition of the expression of VCAM-1 This invention is in the area of methods and compositions for the inhibition of the expression of VCAM-1 and, in particular, for the treatment of diseases mediated by VCAM-1, including cardiovascular and inflammatory diseases.... | 11/14/2000 |
| 6133279 | Therapeutic agents for renal diseases and organ preservatives Herein disclosed are therapeutic agents for renal diseases and organ preservatives containing a compound represented by the general formula (1): ##STR1## wherein X represents an oxygen atom or a group represented by the general formula (2): ... | 10/17/2000 |
| 6127423 | Phenylamidine derivatives, a process for preparing the same and their use as medicaments The invention relates to new phenylamidine derivatives, processes for preparing them and their use as pharmaceutical compositions. The phenylamidines according to the invention correspond to the general formula I ##STR1##... | 10/03/2000 |
| 6100429 | N-benzylidene aminophenylacetylene carbinols This invention provides a process for preparing aminoarylacetylenes comprising reacting a N-arylmethylidene aminoarylhalide with a terminal acetylene in the presence of a base and a catalyst system comprising a palladium catalyst and a cuprous salt to pro... | 08/08/2000 |
| 6066757 | Stilbene compound and process for producing same A stilbene compound is disclosed which has the following general formula (I): ##STR1## wherein R1 and R2 each stand for hydrogen, an alkyl group or an acyl group and Ar1 and Ar2 each stand for a monovalent ... | 05/23/2000 |
| 6040339 | Urea derivatives having ACAT inhibitory activity, their preparation and their therapeutic and prophylactic use Compounds of formula (I): ##STR1## wherein: R1 is alkyl; R2a, R2b, R2c and R2d are the same or different and each is hydrogen, optionally substituted alkyl or various other organic groups; R... | 03/21/2000 |
| 6013836 | Insecticidal N'-substituted-N,N'-disubstitutedhydrazines This invention relates to N'-substituted-N,N'-disubstitutedhydrazines of formula I ##STR1## wherein X and X' are independently O, S, or NR; A' and B' are independently substituted or unsubstituted aryl or aromatic heterocycle; wherein F is alkyl... | 01/11/2000 |
| 5998499 | Liquid crystalline (meth)acrylate compounds, composition and method A liquid crystalline compound, a polymeric product formed by polymerization of the liquid crystalline compound, a dental composition including the liquid crystalline compound and method of using the dental composition. Polymerization of the liquid crystal... | 12/07/1999 |
| 5925674 | Cycloalkylcarboxanilides This invention relates to cycloalkylcarboxanilides of the formula ##STR1## which are used to combat pests.... | 07/20/1999 |
| 5880314 | Hydrochalcone derivatives, cosmetic compositions containing said derivatives and methods of producing the same The present invention can provide cosmetic formulations comprising hydrochalcone compounds of the general formula (I): ##STR1## in which R1 to R4 are each independently H or --COR, and R is an alkyl group having 1-20 carbon atom... | 03/09/1999 |
| 5874611 | Butenyl hydroquinone derivatives A hydroquinone derivative (I) represented by the following formula: ##STR1## wherein R1 is a hydrogen atom, acetyl group or benzoyl group, such hydroquinone derivative being useful as an intermediate for chroman derivatives useful as a blo... | 02/23/1999 |
| 5808137 | Chalcones and esters thereof with antiproliferative activity in uterus, ovary and breast tumors The present invention relates to the use of some natural or synthetic chalcones and the esters thereof with straight or branched aliphatic acids, saturated and unsaturated, containing up to 22 carbon atoms in the therapy and prevention of the uterus, ovar... | 09/15/1998 |
| 5808139 | Non-steroid progesterone receptor agonist and antagonist and compounds and methods Non-steroidal compounds which are high affinity, high specificity ligands for progesterone receptors are disclosed. The compounds include synthetic derivatives of cyclocymopol and its diastereomers, spectroscopically and chromatographically pure (3R)-cycl... | 09/15/1998 |
| 5798348 | Fatty-acid monoesters of estrogens for the treatment of obesity and/or overweight The pharmaceutical and/or cosmetic compositions for treatment of obesity and/or overweight contain an effective amount of a fatty-acid monoester of an estrogen and a fatty acid wherein the estrogen is estrone, diethylstilbestrol, estriol, estradiol or eth... | 08/25/1998 |
| 5624961 | Benzylaminoethoxybenzene derivatives, production thereof and use thereof Novel benzylaminoethoxybenzene derivatives of the formula (I) ##STR1## wherein R1 is a hydrogen atom, a lower alkyl, a lower hydroxyalkyl, a lower alkoxyalkyl, an allyl or a benzyl; R2 is a hydrogen atom, a lower alkyl, a lower ... | 04/29/1997 |